Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T12:12:55.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T10:18:31.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The website has added new features for data download options and selection fields, while several key government health-related URLs have been removed.
    Difference
    14%
    Check dated 2024-11-23T03:57:59.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, adding several new links including those to HHS, NIH, and NLM, while the previous version 2.12.1 has been removed.
    Difference
    17%
    Check dated 2024-11-08T17:55:42.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.3%
    Check dated 2024-11-01T10:20:55.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.0 on October 24, 2024, following the removal of version 2.11.2 on October 15, 2024.
    Difference
    1.0%
    Check dated 2024-10-25T00:23:24.000Z thumbnail image

Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.